Aldehyde Dehydrogenase bright (ALDHbr) cells have been used in preclinical models and human clinical trials in the applications such as critical limb ischemia, ischemic stroke, acute liver failure and ischemic heart failure. Listen to the webinar recording on how ALDHbr cells and the ALDHbr cell detection kits - ALDEFLUOR™ and ALDECOUNT™ could be used in regenerative medicine research.
To view the webinar, please complete the form, or sign in to your account.